Botanix Pharmaceuticals updates on meeting with FDA
AusBiotech’s BiotechDispatch featured our BTX 1801 antimicrobial program update today.
Read the full article here.
AusBiotech’s BiotechDispatch featured our BTX 1801 antimicrobial program update today.
Read the full article here.
Botanix has appeared in a must-read feature about antimicrobial resistance (AMR) in the latest edition of AusBiotech’s Australasian Biotechnology Journal.
It is titled, “Antimicrobial resistance: a global health emergency”.
A quote from WHO Director-General Dr Tedros Adhanom Ghebreyesus, featured in the story, points to the importance of the work we are doing in this space:
“AMR is a slow tsunami that threatens to undo a century of medical progress. A record number of countries are now monitoring and reporting on antibiotic resistance to WHO”.
Read the full story on pages 52-54 here.
AUSTRALIA
D2, 661 Newcastle Street, Leederville WA 6007
USA
3602 Horizon Drive, Suite 160, King of Prussia, PA 19406
Be notified of important news from Botanix.
AU +61 8 6555 2945
US + 1 445 300 3403
info@botanixpharma.com